Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases.

European journal of cancer (Oxford, England : 1990) - 1 Nov 2009

Heitz Florian, Harter Philipp, Lueck Hans-Joachim, Fissler-Eckhoff Annette, Lorenz-Salehi Fatemeh, Scheil-Bertram Stefanie, Traut Alexander, du Bois Andreas

Abstract excerpt

PURPOSE: Evaluation of the influence of immunohistochemically defined breast cancer (BC) subtypes and other risk factors on the development of cerebral metastases (CM). METHODS: Exploratory analysis of a hospital-based prospective tumour registry including all patients with primary BC treated in our EUSOMA breast unit between 1998 and 2006. RESULTS: The study cohort contained 2441 patients, including 284 patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Disease-Free Survival

Share to Immunohistochemistry

Share to Receptor, ErbB-2

Share to Receptors, Estrogen

Share to Receptors, Progesterone

Share to Risk Factors

Source

Identifiers

PMID: 19643597
DOI: 10.1016/j.ejca.2009.06.027

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases.PMID 19643597Read ↗

BRCA1 Mutations Associated With Increased Risk of Brain Metastases in Breast Cancer: A 1: 2 Matched-pair Analysis.Semantic proximity Read ↗

Insights into the Steps of Breast Cancer–Brain Metastases Development: Tumor Cell Interactions with the Blood–Brain BarrierSemantic proximity Read ↗

Risk of metastasis in BRCA2 carriers diagnosed with triple-negative breast cancer.Semantic proximity Read ↗

HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer.Semantic proximity Read ↗

Gene expression profiling in a retrospective real-world cohort of breast cancer brain metastases and paired primary tumors identifies biological changes with potential therapeutic implicationsSemantic proximity Read ↗

Genomics of breast cancer brain metastases: a meta-analysis and therapeutic implicationsSemantic proximity Read ↗

Clinical and molecular features of resected breast cancer brain metastases: a single center retrospective cohort study.Semantic proximity Read ↗

Primary breast cancer phenotypes associated with propensity for central nervous system metastases.Semantic proximity Read ↗

CNS metastases of breast cancer show discordant immunohistochemical phenotype compared to primary.Semantic proximity Read ↗

Spectrum of breast cancer metastasis in BRCA1 mutation carriers: highly increased incidence of brain metastasesSemantic proximity Read ↗

Distinct gene expression profiles between primary breast cancers and brain metastases from pair-matched samplesSemantic proximity Read ↗

Breast cancer brain metastases: biology and new clinical perspectives.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.